Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: trichomoniasis

  • Improve Screening and Retesting for Trichomoniasis

    Infection by the protozoan Trichomonas vaginalis is the most common nonviral sexually transmitted infection, with an estimated 6.8 million cases in the United States annually. It can go undiagnosed because most infected people (up to three out of four) do not experience symptoms. Left undiagnosed and untreated, trichomoniasis can increase the risk of pelvic inflammatory disease, infertility, and acquiring HIV and other STIs.

  • Clinicians Appear to Under-Screen, Under-Treat Patients with STIs

    Insurance claims data from tens of millions of outpatient cases of patients seeking treatment for lower genitourinary tract symptoms revealed testing for sexually transmitted infections occurred in only 17.6% of all episodes.

  • Older Adults Also at Risk of STIs, Suggesting Screening Needed

    Clinicians and researchers pay less attention to the sexual health needs of older adult than other ages groups. Evidence suggests this population’s risk of sexually transmitted infections is climbing.

  • CDC Updates Trichomoniasis Treatment Guidelines

    Although trichomoniasis likely is the most common nonviral STI in the world, and is potentially dangerous for birth outcomes, it is largely overlooked in screening and diagnosis. The CDC recently updated its STI treatment guidelines, recommending women with trichomoniasis receive multidose metronidazole 500 mg twice daily for seven days.
  • Updated 2021 Sexually Transmitted Infections Treatment Guidelines

    The CDC updated their sexually transmitted infections treatment guidelines with new recommendations for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, and Mycoplasma genitalium.

  • Updated Sexually Transmitted Infection Guidelines

    The Centers for Disease Control and Prevention has updated their recommendations for the treatment of several sexually transmitted infections, including gonorrhea, trichomoniasis, bacterial vaginosis, pelvic inflammatory disease, and those due to Chlamydia trachomatis and Mycoplasma genitalium.

  • Study Finds High Prevalence of STIs in Pregnant Adolescents

    A new study revealed that teenagers who give birth have a higher-than-expected risk of sexually transmitted infections and high rates of preterm births and chorioamnionitis.

  • Study Examines Disparity of Trichomoniasis

    Results of a new analysis indicate that trichomoniasis disproportionately affects the black community. Data indicate that while the prevalence of Trichomonas vaginalis infection was 0.03% and 0.8% among males and females of other races/ethnicities, the prevalence was significantly higher among black males and females at 4.2% and 8.9%, respectively.